REGENXBIO, Inc. (RGNX)

8.55 -0.01 (-0.12%) USD  |  NASDAQ  |  Sep 11, 15:44
More

REGENXBIO Gross Profit (TTM) : 135.34M for June 30, 2026

Gross Profit (TTM) Chart

View Gross Profit (TTM) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 135.34M
March 31, 2026 44.37M
December 31, 2025 134.53M
September 30, 2025 124.86M
June 30, 2025 112.59M
March 31, 2025 108.01M
December 31, 2024 33.55M
September 30, 2024 29.31M
June 30, 2024 33.62M
March 31, 2024 32.02M
December 31, 2023 35.71M
September 30, 2023 43.50M
June 30, 2023 41.22M
March 31, 2023 52.21M
December 31, 2022 54.47M
September 30, 2022 413.02M
June 30, 2022 417.00M
March 31, 2022 409.96M
December 31, 2021 408.95M
September 30, 2021 45.04M
June 30, 2021 110.57M
March 31, 2021 110.31M
December 31, 2020 110.45M
September 30, 2020 107.42M
Date Value
June 30, 2020 38.38M
March 31, 2020 32.84M
December 31, 2019 19.84M
September 30, 2019 50.41M
June 30, 2019 43.92M
March 31, 2019 74.98M
December 31, 2018 204.88M
September 30, 2018 169.96M
June 30, 2018 166.41M
March 31, 2018 135.69M
December 31, 2017 6.351M
September 30, 2017 6.018M
June 30, 2017 5.683M
March 31, 2017 3.018M
December 31, 2016 3.505M
September 30, 2016 5.697M
June 30, 2016 6.615M
March 31, 2016 5.791M
December 31, 2015 6.085M
September 30, 2015 4.919M
June 30, 2015 4.036M
March 31, 2015 2.983M
March 31, 2014 2.392M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
AbbVie, Inc. 45.98B
Capricor Therapeutics, Inc. -2.095M
United Therapeutics Corp. 2.717B
Ardelyx, Inc. 422.15M
Biomea Fusion, Inc. -0.513M